Updates are available Correction dated 2022-01-12
Click to view Correction: https://doi.org/10.1038/s41591-021-01670-6
-
Authors
Kraemer, Moritz U. G. http://orcid.org/0000-0001-8838-7147
Pybus, Oliver G.
Fraser, Christophe http://orcid.org/0000-0003-2399-9657
Cauchemez, Simon http://orcid.org/0000-0001-9186-4549
Rambaut, Andrew http://orcid.org/0000-0003-4337-3707
Cowling, Benjamin J.
-
Funding
Funding for this research was provided by:
Rockefeller Foundation
- License Information
-
More Information
Article History
First Online: 8 November 2021
Change Date: 12 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-021-01670-6
Competing interests
: C.F. is a consultant for The Public Health Company. B.J.C. has consulted for AstraZeneca, GSK, Moderna, Roche and Sanofi Pasteur. A.R. and O.G.P. have received consulting fees from AstraZeneca. M.U.G.K. and S.C. declare no competing interests.
Free to read: This content has been made available to all.
